Model
Edge
Five Prime Therapeutics, Inc.
0001329049
Filing type
4
Filing date
Mar 3, 2019
Updated
Mar 4, 2019 ยท 11:21 AM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership